Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

AGM Statement

25 Jan 2008 07:01

Marston's PLC25 January 2008 25th January 2008 MARSTON'S PLC ('Marston's') AGM AND INTERIM MANAGEMENT STATEMENT 16 weeks to 19 January 2008 Marston's PLC issues the following Interim Management Statement in advance ofthe Company's Annual General Meeting to be held at 12 noon today. Trading Group sales were 7.9% ahead of last year for the 16 week period reflecting theacquisitions of Sovereign Inns, Eldridge Pope and Ringwood Brewery in 2007. In Marston's Inns & Taverns, our managed pub division, like-for-like salesincreased by 1.0% for the 16 week period to 19 January 2008 against strongcomparatives with reported like-for-like sales growth of 7.0% for the sameperiod last year. In the last 8 weeks to 19 January 2008 like-for-like saleswere 0.1% ahead of last year. Food sales have continued to show excellentlike-for-like sales growth of 9.5%, although higher margin wet sales and machineincome were 2.6% and 9.8% below last year respectively. In Marston's Pub Company, our tenanted and leased pub division, like-for-likeprofit was 0.6% below last year in the period with growth in rental incomeoffset by weak volumes and machine income in line with market trends. In Marston's Beer Company overall volumes are below last year. However we havecontinued to increase market share in a weak beer market with regional premiumales from the Jennings and Ringwood breweries showing good growth. This summerwe aim to build on our successful association with cricket in England and Walesthrough becoming the Official Beer of the Twenty20 Cup. Costs across the Group have been well controlled notwithstanding inflationarypressures in brewing and food purchasing, but the changes in sales mix describedabove will continue to have an impact on operating margins. Financing and cash flow Net debt and cash flow are in line with our expectations. We announced on 19November 2007 the terms of a £330 million tap of our securitisation whichcompleted on 22 November 2007. Following this refinancing nearly all of ourborrowings are at effectively fixed rates with a blended cost of debt ofapproximately 6.1%. Since 30 September 2007 we have purchased 8.7 million shares at a total cost ofaround £29 million, meeting our stated target of returning £150 million toshareholders in the 2007 calendar year. The Board Peter Lipscomb will retire from the Board following this Annual General Meeting,and we thank him for the significant contribution he has made to the developmentof the Company since he joined in 2000. On 21 January 2008 we announced theappointment of Neil Goulden, Chief Executive of The Gala Coral Group, as aNon-Executive Director from 31 March 2008 and we look forward to welcoming himto the Board. Outlook We remain cautious about the outlook for 2008 as a consequence of the smokingban, weaker consumer confidence and pressures on costs and margins. However, ourhigh quality pub estate is well positioned to exploit favourable market trendsincluding the growth in casual dining. Our value for money offers andmid-market position are appropriate for the current economic climate. Ralph Findlay, Chief Executive, commented as follows: "Marston's has a clear strategy for growth and a strong balance sheet supportedby a substantially freehold pub estate which provides us with significantoperational and financial flexibility. We are working hard to reduce the impactof rising costs while supporting tenants and lessees in this challenging market.Our new build pub programme is on track and our pub estate is well positionedfor the current economic climate and for longer term market trends." The next report to shareholders will be on 23 May when Marston's issues itsinterim results for the 26 weeks to 29 March 2008. An Interim ManagementStatement will be issued in early July followed by a pre-close trading update inearly October in respect of the 53 week period to 4 October 2008. There will be a conference call for analysts and investors at 8.30am today. Toaccess the call, please contact James White at Hudson Sandler on +44 (0) 207 7964133. ENQUIRIES: Marston's PLC Hudson SandlerRalph Findlay, Chief Executive Andrew Hayes / Nick LyonPaul Inglett, Finance Director Tel: 01902 329516 Tel: 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.